The DOI matches its Crossref record; 153 of the 155 references it cites were found in a registry or an index, and 2 are not checked yet.
The Bacterial Flora in Inflammatory Bowel Disease: Current Insights in Pathogenesis and the Influence of Antibiotics and Probiotics
Abstract
The pathogenesis of inflammatory bowel disease (IBD) remains unknown, although in recent years more data have become available. The contribution of genetic and environmental factors is evident, and the luminal bacterial flora plays a major role in the initiation and perpetuation of chronic IBD. Animal models of IBD have shown that colitis does not occur in a germ-free environment. In human IBD, inflammation is present in parts of the gut containing the highest bacterial concentrations. Moreover, the terminal ileum, caecum and rectum are areas of relative stasis, providing prolonged mucosal contact with luminal contents. Enhanced mucosal permeability may play a pivotal role in maintaining a chronic inflammatory state, due to a genetic predisposition or as a result of direct contact with bacteria or their products. A detective epithelial barrier may cause a loss of tolerance to the normal enteric flora. Furthermore, an increased mucosal absorption of viable bacteria and bacterial products is found in IBD. Serum and secreted antibodies are increased and mucosal T-lymphocytes that recognize luminal bacteria are present. However, there is evidence that the immune system reacts over aggressively towards the normal luminal flora rather than the flora being altered in IBD. Several approaches have been used in attempts to discover a specific microbial agent in the cause of IBD. These include demonstration of the presence of organisms or specific antigens in affected tissues, culture of microbes firm the affected tissues, demonstration of serological responses to several agents, and localization and detection of individual pathogen-specific nucleic acid sequences in affected tissue by in situ hybridization and polymerase chain reaction. So far, no specific micro-organism has been directly associated with the pathogenesis of IBD. Analysis of the luminal enteric flora, however, has revealed differences in the composition of this flora compared to healthy controls. In Crohn disease, concentrations of Bacteroides, Eubacteria and Peptostreptococcus are increased, whereas Bifidobacteria numbers are significantly reduced. Furthermore, in ulcerative colitis, concentrations of facultative anaerobic bacteria are increased. The arrival of new molecular techniques qualifying and quantifying the complex intestinal flora has induced a revival of interest in this microflora. Therapeutic approaches geared towards changing the environment at the mucosal border have been attempted by the use of elemental diets, total parenteral nutrition, surgical diversion of the faecal stream and antibiotics. Over the past few years, the use of probiotics in IBD and other intestinal disorders has gained attention. Strengthened by promising experimental data and commercial interests, research in this field is rapidly expanding. Manipulation of the colonic bacteria with antibiotic drugs and probiotic agents may prove to be more effective and better tolerated than immunosuppressants in the future.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Imbalanced microbiota may be one such factor, as deviations in microbiota have been seen in IBS 23-25 and as studies on inflammatory bowel disease imply that the microbiota is able to trigger mucosal inflammation. 26”
From Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota (2008) · cites this paper as [26]
In the citing paper
“Microbiota composition is tightly interlinked with inflammation. 26”
From Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota (2008) · cites this paper as [26]
Citations
Cites
Heid, C. A., Stevens, J., Livak, K. J., & Williams, P. M. (1996) · Genome Research · doi:10.1101/gr.6.10.986 · Cited by 6,174
UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS
ROBINWARREN, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92719-8 · Cited by 3,597
MICROBIAL ECOLOGY OF THE GASTROINTESTINAL TRACT
Savage, D. C. (1977) · Annual Review of Microbiology · doi:10.1146/annurev.mi.31.100177.000543 · Cited by 2,436
Inflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059
Muyzer, G., & Smalla, K. (1998) · Antonie van Leeuwenhoek · doi:10.1023/a:1000669317571 · Cited by 2,044
Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin
Gibson, G. R., Beatty, E. R., Wang, X., & Cummings, J. H. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90192-2 · Cited by 1,528
16S rRNA sequences reveal numerous uncultured microorganisms in a natural community
Ward, D. M., Weller, R., & Bateson, M. M. (1990) · Nature · doi:10.1038/345063a0 · Cited by 1,383
Identification of the Uncultured Bacillus of Whipple’s Disease
Relman, D. A., Schmidt, T. M., MacDermott, R. P., & Falkow, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207303270501 · Cited by 1,157
Rembacken, B., Snelling, A., Hawkey, P., Chalmers, D., & Axon, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06343-0 · Cited by 1,101
Karmali, M., Petric, M., Steele, B., & Lim, C. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91795-6 · Cited by 1,035
Research works printed but not linked: 19
- Gorbach SL Levitan R. Intestinal flora in health and gastrointestinal diseases. In: Glass GBJ editor. Progress in gastroenterology vol. 2. New York: Grune and Stratton; 1970. p. 252–75.
- Drasar BS Hill MJ. Human intestinal microflora. New York: Academic Press; 1974.
- Chadwick VS Anderson RP. Microorganisms and their products in inflammatory bowel disease. In: McDermott RP Stimpson WF editors. Inflammatory bowel disease. New York: Elsevier; 1992. p. 241–58.
- Neutra MR Giannasca PJ et al. M cells and microbial pathogens. In: Blaser MJ Smith PD Ravdin JI Greenberg JB Guerrant RL editors. Infections of the gastrointestinal tract. New York: Raven Press; 1995. p. 163–78.
- Sartor RB. Microbial factors in the pathogenesis of Crohn’s disease ulcerative colitis and experimental intestinal inflammation. In: Kirsner JB editor. Inflammatory bowel disease 5th ed. Philadelphia: W. B. Saunders; 2000. p. 153–78.
- Bouma G Poen AC Garcia-Gonzalez MA Schreuder GMT Felt-Bersma RJF Meuwissen SGM et al. HLA-DR3B1*03 but not the TNFa-308 promoter gene polymorphism protection against fistulising Crohn’s disease. Immunogenetics 1998;47: 451–5. · doi:10.1007/s002510050382
- Stokkers PCF, Reitsma PH, Tytgat GNJ, van Deventer SJH. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut 1999;45:395–401.
- Thomas GA, Rhodes J, Green JT. Inflammatory bowel disease and smoking—a review. Am J Gastroenterol 1998;43:144–9.
- Russel MGWM, Dorant E, Brummer RJM, van de Kruys MA, Muris WJ, Bergers JM, et al. Appendectomy and the risk of developing ulcerative colitis or Crohn’s disease: result of a large case-control study. Gastroenterology 1997;113:377–82.
- Miner PB. Factors influencing the relapse of patients with inflammatory bowel disease. Am J Gastroenterol 1997;92:1S–4S.
- Chiodini RJ, van Kruiningen HJ, Thayer Jr WR, Merkal RS, Coutu JA. Possible role of mycobacteria in inflammatory bowel disease. An unclassifi ed mycobacterium species isolated from patients with Crohn’s disease. Dig Dis Sci 1984;29: 1073–9.
- Stein R, Hanauer SB. Life-threatening complications of IBD: How to handle fulminant colitis and toxic megacolon. J Crit Illness 1998;13:518–21.
- Becker JM, Onderdonk AB. Bacterial dysbiosis in the pathogenesis of ileal pouchitis. Gastroenterology 1994;106:A650.
- Greenbloom SL, Steinhart AH, Greenberg GR. Combination ciprofloxacin and metronidazole for active Crohn’s disease. Can J Gastroenterol 1998;12:53–6.
- 10.1111/j.1572-0241.1999.935_q.x · doi:10.1111/j.1572-0241.1999.935_q.x · Paper page
- Solomon MJ, McLeod RS, O’Connor BI, Steinhart AH, Greenberg GR, Cohen Z. Combination ciprofloxacin and metronidazole in severe perianal Crohn’s disease. Can J Gastroenterol 1993;7:571–3.
- Schaafsma G. State of the art concerning probiotic strains in milk products. IDF Nutr Newsl 1996;5:241–5.
- 10.1111/j.1574-695x.1999.tb01381.x · doi:10.1111/j.1574-695x.1999.tb01381.x · Paper page
- Gorbach SL, Chang T, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987;ii:1519.
Cited by
Machiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304833 · Cited by 1,904
Sartor, R. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.024 · Cited by 1,052
Wehkamp, J., Harder, J., Weichenthal, M., Schwab, M., Schäffeler, E., Schlee, M., Herrlinger, K. R., Stallmach, A., Noack, F., Fritz, P., et al. (2004) · Gut · doi:10.1136/gut.2003.032805 · Cited by 823
Dysbiosis in inflammatory bowel disease
Tamboli, C. P., Neut, C., Desreumaux, P., & Colombel, J. F. (2004) · Gut · doi:10.1136/gut.53.1.1 · Cited by 743
Rapid and Noninvasive Metabonomic Characterization of Inflammatory Bowel Disease
Marchesi, J. R., Holmes, E., Khan, F., Kochhar, S., Scanlan, P., Shanahan, F., Wilson, I. D., & Wang, Y. (2007) · Journal of Proteome Research · doi:10.1021/pr060470d · Cited by 631
Metadata
- Authors
- Linskens, R. K., Huijsdens, X. W., Savelkoul, P. H. M., Vandenbroucke-Grauls, C. M. J. E., & Meuwissen, S. G. M.
- Affiliations
- Vrije Universiteit Amsterdam (NL)
- Depts. of Gastroenterology and Medical Microbiology, Academic Hospital Vrije Universiteit Amsterdam, The Netherlands
- ORCID
- Savelkoul, P. H. M.
- Venue
- Scandinavian Journal of Gastroenterology
- Publisher
- Informa UK Limited
- Published
- 2001-01
- Volume
- 36
- Issue
- 234
- Pages
- 29-40
- ISSN
- 0036-5521 (ISSN-L)
- 1502-7708
- OpenAlex
- W2119336597
- Cited by
- 233
- References
- 152
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 2 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 5 · 2018: 4 · 2017: 8 · 2016: 10 · 2015: 8 · 2014: 6 · 2013: 16 · 2012: 11
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Scandinavian Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- inflammatory bowel disease, gut microbiota, bacterial flora, Crohn's disease, ulcerative colitis, pathogenesis, mucosal permeability, epithelial barrier function, mucosal immunity, Bacteroides, Bifidobacterium, Peptostreptococcus, facultative anaerobes, probiotics, antibiotics, elemental diet, total parenteral nutrition, germ-free animals
- MeSH terms
- Anti-Bacterial Agents, Colon, Humans, Intestinal Mucosa, Inflammatory Bowel Diseases, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Bacterial Flora in Inflammatory Bowel Disease: Current Insights in Pathogenesis and the Influence of Antibiotics and Probiotics. https://app.cochat.ai/papers/10.1080/003655201753265082
- The paper
- Linskens, R. K., Huijsdens, X. W., Savelkoul, P. H. M., Vandenbroucke-Grauls, C. M. J. E., & Meuwissen, S. G. M. (2001). The Bacterial Flora in Inflammatory Bowel Disease: Current Insights in Pathogenesis and the Influence of Antibiotics and Probiotics. Scandinavian Journal of Gastroenterology. https://doi.org/10.1080/003655201753265082
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.